How gut bacteria can impact treatments for cancer

by Bob Yirka , Medical XpressTreatment with 3-IAA and FIRINOX results in reduced autophagic activity. a, Gnotobiotic mice were colonized with R microbiota and KPC cells were orthotopically injected. M

Updated on: December 19,2023

How gut bacteria can impact treatments for cancer

by Bob Yirka , Medical XpressTreatment with 3-IAA and FIRINOX results in reduced autophagic activity. a, Gnotobiotic mice were colonized with R microbiota and KPC cells were orthotopically injected. M

Updated on:December 19,2023

Scientists find dramatic rise in anal cancer in Midwest and Southeast

by Caroline Wallace,Medical University of South CarolinaCredit: Unsplash/CC0 Public DomainSouth Carolina is seeing one of the fastest rises in anal cancer incidence among women and anal cancer m

Updated on: December 27,2023

Scientists find dramatic rise in anal cancer in Midwest and Southeast

by Caroline Wallace,Medical University of South CarolinaCredit: Unsplash/CC0 Public DomainSouth Carolina is seeing one of the fastest rises in anal cancer incidence among women and anal cancer m

Updated on:December 27,2023

The Sweet Dilemma: Fructose's Impact on Cancer and Immunity

Updated on: July 13,2024

The Sweet Dilemma: Fructose's Impact on Cancer and Immunity

Updated on:July 13,2024

HER2+ early breast cancers where shorter-course trastuzumab could be an option

byEuropean Society for Medical OncologyCredit: European Society for Medical OncologyWomen with HER2-positive early breast cancer with small tumours have similar disease-free survival and lower r

Updated on: December 18,2023

HER2+ early breast cancers where shorter-course trastuzumab could be an option

byEuropean Society for Medical OncologyCredit: European Society for Medical OncologyWomen with HER2-positive early breast cancer with small tumours have similar disease-free survival and lower r

Updated on:December 18,2023

Overexpressed Cyclin D1 and CDK4 proteins are responsible for the resistance to CDK4/6 inhibitor in some breast cancer

byScience China PressThe CDK4/6 inhibitors-resistant breast cancer cells expressed more Cyclin D1 and CDK4 proteins than the parental cells (Upper left). PI3K pathway was hyper-activated in the

Updated on: December 23,2023

Overexpressed Cyclin D1 and CDK4 proteins are responsible for the resistance to CDK4/6 inhibitor in some breast cancer

byScience China PressThe CDK4/6 inhibitors-resistant breast cancer cells expressed more Cyclin D1 and CDK4 proteins than the parental cells (Upper left). PI3K pathway was hyper-activated in the

Updated on:December 23,2023

Using a machine learning algorithm with cancer methylation signatures to diagnose colorectal cancer

by Bob Yirka , Medical XpressCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0A team of researchers affiliated with a large number of institutions in China has used a m

Updated on: December 20,2023

Using a machine learning algorithm with cancer methylation signatures to diagnose colorectal cancer

by Bob Yirka , Medical XpressCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0A team of researchers affiliated with a large number of institutions in China has used a m

Updated on:December 20,2023

CAR T cell therapy for T cell lymphoma shows promise in phase I trial

by Molly Chiu,Baylor College of MedicineCredit: Pixabay/CC0 Public DomainResearchers at the Center for Cell and Gene Therapy at Baylor College of Medicine, Texas Children's Hospital, and Hou

Updated on: January 26,2024

CAR T cell therapy for T cell lymphoma shows promise in phase I trial

by Molly Chiu,Baylor College of MedicineCredit: Pixabay/CC0 Public DomainResearchers at the Center for Cell and Gene Therapy at Baylor College of Medicine, Texas Children's Hospital, and Hou

Updated on:January 26,2024

Step-by-Step "Blood Replacement": A New ADC Therapy for Precise Tumor Elimination

Updated on: May 29,2024

Step-by-Step "Blood Replacement": A New ADC Therapy for Precise Tumor Elimination

Updated on:May 29,2024

Shortened radiation course safe for early-stage breast cancer patients with elevated risk of recurrence

byAmerican Society for Radiation OncologyMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainA three-week course of radiation therapy is as safe and

Updated on: January 04,2024

Shortened radiation course safe for early-stage breast cancer patients with elevated risk of recurrence

byAmerican Society for Radiation OncologyMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainA three-week course of radiation therapy is as safe and

Updated on:January 04,2024

Urban and rural rates of childhood cancer survival the same, study finds

by Neil Schoenherr,Washington University in St. LouisChildhood and adolescent cancer survival in the United States does not vary by rural/urban residence at the time of diagnosis, finds a new st

Updated on: December 18,2023

Urban and rural rates of childhood cancer survival the same, study finds

by Neil Schoenherr,Washington University in St. LouisChildhood and adolescent cancer survival in the United States does not vary by rural/urban residence at the time of diagnosis, finds a new st

Updated on:December 18,2023

Mechanism for silencing gene expression targets the culprit behind a deadly liver cancer

by Sanford M. Simon,Rockefeller UniversityASGR1 in FLC. (A) RNA expression analysis of ASGR1 across patient samples. (B) Immunofluorescence of ASGR1 in tumor-adjacent healthy liver, primary tumo

Updated on: March 20,2024

Mechanism for silencing gene expression targets the culprit behind a deadly liver cancer

by Sanford M. Simon,Rockefeller UniversityASGR1 in FLC. (A) RNA expression analysis of ASGR1 across patient samples. (B) Immunofluorescence of ASGR1 in tumor-adjacent healthy liver, primary tumo

Updated on:March 20,2024

Testing cells for cancer drug resistance

byRuhr-Universitaet-BochumSamir El-Mashtoly (right) and Klaus Gerwert in the lab at Ruhr-Universität Bochum. Credit: Michael SchwettmannBiophysicists at Ruhr-Universität Bochum (RUB) have demons

Updated on: December 18,2023

Testing cells for cancer drug resistance

byRuhr-Universitaet-BochumSamir El-Mashtoly (right) and Klaus Gerwert in the lab at Ruhr-Universität Bochum. Credit: Michael SchwettmannBiophysicists at Ruhr-Universität Bochum (RUB) have demons

Updated on:December 18,2023